Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Distribution of Late Loss of Both SES and PES
(A) Distribution of late loss of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) for the total cohort. Late loss was not normally distributed (p = 0.0001) and was higher in the PES group: 0.45 mm (interquartile ratio [IQR] 0.07 to 0.99) compared with 0.23 mm (IQR –0.02 to 0.69) after SES, p = 0.0001. (B) Distribution of late loss of both SES and PES for nonrestenotic lesions. Late loss was normally distributed and was significantly higher in the PES group: 0.32 ± 0.55 mm compared with 0.06 ± 0.52 mm, p = 0.0001. (C) Distribution of late loss of both SES and PES for restenotic lesions. Late loss was normally distributed, and there was no difference in late loss between the 2 groups: PES 1.78 ± 0.72 mm compared with SES 1.7 ± 0.69 mm, p = 0.39.
|
